INSIGHTS ON DRUG DEVELOPMENT

• Lipids Center Of Excellence

  Examine high-quality, GMP-compliant lipids that are engineered for pharmaceutical and gene therapy applications, with options ranging from standard formulations to custom blends for improved stability.

• How Proactive Regulatory Planning Supports Improved Drug Formulation And Manufacture

  Integrating regulatory strategy with R&D planning early in drug development helps to minimize formulation risks and align manufacturing with compliance while preventing costly delays.

• Beyond Particle Counting: Why Modern Biologics Need Particle Forensics

  High particle counts don’t always mean high risk. Identifying particle type and origin—not just quantity—avoids false alarms, protects timelines, and turns data into action.

• Flexibility In Drug Development: From Tactical Response To Strategic Imperative

  Build flexibility into your drug development strategy to navigate change effectively, maintain momentum, and drive successful outcomes across every stage of the lifecycle.

• Early-Phase Injectable Formulation Development

  4/6/2026

  Discover how expert-driven strategies and data-centric tools can help you overcome formulation challenges and accelerate the development of stable, high-performance injectable therapeutics.

• Systematic Strategy To Reduce The Cost Of Goods Sold

  3/26/2026

  Learn key ways to cut biologics manufacturing costs through smarter process design, material choices, and supply resilience — driving more efficient, reliable, and commercially sustainable production.

• Deciphering The Complexity Of Therapeutic Biologics

  3/26/2026

  This session breaks down essential analytical approaches that strengthen biologics development, from defining critical quality attributes to supporting comparability and regulatory readiness. 

• Flexible Therapeutic Development: Balancing Speed, Cost, and Process

  3/24/2026

  Microbial development for first‑in‑human studies requires coordinated cell line, fermentation, and purification strategies to accelerate timelines while controlling cost and process robustness.